AIM: To evaluate the role of genetic factors in the pathogenesis of idiopathic infant cholestasis. METHODS: We performed a case-control study, including 78 infants with idiopathic infant cholestasis and 113 healthy infants as controls. Genomic DNA was extracted from peripheral venous blood leukocytes using phenol chloroform methodology. Polymerase chain reaction was used to amplify the multidrug resistance protein 3 (MDR3) R652G fragment, and products were sequenced using the ABI 3100 Sequencer. RESULTS: The R652G single nucleotide polymorphism (SNP) was significantly more frequent in healthy infants (allele frequency 8.0%) than in patients (allele frequency 2.60%) (P < 0.05), odds ratio, 0.29; 95% confidence interval, 0.12-0.84. The conjugated bilirubin in patients with the AG genotype was significantly lower than in those with the AA genotype (44.70 +/- 6.15 micromol/L vs 95.52 +/- 5.93 micromol/L, P < 0.05). CONCLUSION: MDR3 R652G is negatively correlated with idiopathic infant cholestasis. Children with the R652G SNP in Guangxi of China may have reduced susceptibility to infant intrahepatic cholestasis.
AIM: To evaluate the role of genetic factors in the pathogenesis of idiopathic infantcholestasis. METHODS: We performed a case-control study, including 78 infants with idiopathic infantcholestasis and 113 healthy infants as controls. Genomic DNA was extracted from peripheral venous blood leukocytes using phenol chloroform methodology. Polymerase chain reaction was used to amplify the multidrug resistance protein 3 (MDR3) R652G fragment, and products were sequenced using the ABI 3100 Sequencer. RESULTS: The R652G single nucleotide polymorphism (SNP) was significantly more frequent in healthy infants (allele frequency 8.0%) than in patients (allele frequency 2.60%) (P < 0.05), odds ratio, 0.29; 95% confidence interval, 0.12-0.84. The conjugated bilirubin in patients with the AG genotype was significantly lower than in those with the AA genotype (44.70 +/- 6.15 micromol/L vs 95.52 +/- 5.93 micromol/L, P < 0.05). CONCLUSION:MDR3R652G is negatively correlated with idiopathic infantcholestasis. Children with the R652G SNP in Guangxi of China may have reduced susceptibility to infantintrahepatic cholestasis.
Authors: S S Strautnieks; A F Kagalwalla; M S Tanner; A S Knisely; L Bull; N Freimer; S A Kocoshis; R M Gardiner; R J Thompson Journal: Am J Hum Genet Date: 1997-09 Impact factor: 11.025
Authors: E Jacquemin; J M De Vree; D Cresteil; E M Sokal; E Sturm; M Dumont; G L Scheffer; M Paul; M Burdelski; P J Bosma; O Bernard; M Hadchouel; R P Elferink Journal: Gastroenterology Date: 2001-05 Impact factor: 22.682
Authors: J M de Vree; E Jacquemin; E Sturm; D Cresteil; P J Bosma; J Aten; J F Deleuze; M Desrochers; M Burdelski; O Bernard; R P Oude Elferink; M Hadchouel Journal: Proc Natl Acad Sci U S A Date: 1998-01-06 Impact factor: 11.205
Authors: Thomas Lang; Michael Haberl; Diana Jung; Anja Drescher; Robert Schlagenhaufer; Andrea Keil; Esther Mornhinweg; Bruno Stieger; Gerd A Kullak-Ublick; Reinhold Kerb Journal: Drug Metab Dispos Date: 2006-06-08 Impact factor: 3.922
Authors: Carmen Lang; Yvonne Meier; Bruno Stieger; Ulrich Beuers; Thomas Lang; Reinhold Kerb; Gerd A Kullak-Ublick; Peter J Meier; Christiane Pauli-Magnus Journal: Pharmacogenet Genomics Date: 2007-01 Impact factor: 2.089
Authors: Christiane Pauli-Magnus; Thomas Lang; Yvonne Meier; Tina Zodan-Marin; Diana Jung; Christian Breymann; Roland Zimmermann; Silke Kenngott; Ulrich Beuers; Christoph Reichel; Reinhold Kerb; Anja Penger; Peter J Meier; Gerd A Kullak-Ublick Journal: Pharmacogenetics Date: 2004-02
Authors: S S Strautnieks; L N Bull; A S Knisely; S A Kocoshis; N Dahl; H Arnell; E Sokal; K Dahan; S Childs; V Ling; M S Tanner; A F Kagalwalla; A Németh; J Pawlowska; A Baker; G Mieli-Vergani; N B Freimer; R M Gardiner; R J Thompson Journal: Nat Genet Date: 1998-11 Impact factor: 38.330
Authors: Suporn Treepongkaruna; Amornphun Gaensan; Paneeya Pienvichit; Ondrej Luksan; A S Knisely; Pattana Sornmayura; Milan Jirsa Journal: World J Gastroenterol Date: 2009-09-14 Impact factor: 5.742